Packaging PrEP to Prevent HIV Among WWID

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

October 8, 2019

Study Completion Date

October 8, 2019

Conditions
HIV/AIDS
Interventions
BEHAVIORAL

PrEP Education and option to accept a PrEP prescription

Participants will receive educational information about PrEP, be offered a PrEP prescription, and those who choose to initiated PrEP will be monitored for side-effects and adherence at their follow-up visit. There is no group assignment within this study and WWID do not have to choose to initiate PrEP. Rather, the goal of this study is to understand factors that impact PrEP initiation (and engagement in the PrEP care continuum).

Trial Locations (1)

19104

Drexel University Dornsife School of Public Health, Philadelphia

All Listed Sponsors
lead

Drexel University

OTHER

NCT03304912 - Packaging PrEP to Prevent HIV Among WWID | Biotech Hunter | Biotech Hunter